Synopsys Company Profile (NASDAQ:SNPS)

Synopsys trades on the NASDAQ under the ticker symbol "SNPS."

Synopsys declared that its board has approved a stock repurchase program on Saturday, June 17th 2017, which authorizes the company to buyback $500,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization authorizes the company to buy up to 4.5% of its stock through open market purchases. Stock buyback programs are often an indication that the company's leadership believes its shares are undervalued.

Synopsys, Inc. (NASDAQ:SNPS) announced its quarterly earnings results on Wednesday, August, 16th. The company reported $0.92 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.92. The firm had revenue of $695.40 million for the quarter, compared to analyst estimates of $691.22 million. Synopsys had a return on equity of 11.60% and a net margin of 12.37%. The firm's revenue was up 13.0% on a year-over-year basis. During the same quarter last year, the company earned $0.76 earnings per share. View Synopsys' Earnings History.

Synopsys is scheduled to release their next quarterly earnings announcement on Tuesday, November, 28th 2017. View Earnings Estimates for Synopsys.

Synopsys issued an update on its FY17 earnings guidance on Monday, September, 11th. The company provided earnings per share guidance of $3.29-3.32 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.31. The company issued revenue guidance of $2.67-2.69 billion, compared to the consensus revenue estimate of $2.68 billion.Synopsys also updated its Q4 guidance to 0.55-0.58 EPS.

9 equities research analysts have issued 12-month target prices for Synopsys' shares. Their predictions range from $60.00 to $90.00. On average, they expect Synopsys' stock price to reach $83.00 in the next year. View Analyst Ratings for Synopsys.

Here are some recent quotes from research analysts about Synopsys stock:

• 1. According to Zacks Investment Research, "Synopsys is a vendor of electronic design automation (EDA) software to the semiconductor and electronics industries. Shares of Synopsys has outperformed the industry over the past one year. Synopsys recently completed the buyout of a privately-held self-funded company, QuantumWise. We believe that the company’s sustained focus on introducing new products, acquisitions and deal wins will continue to boost results, going ahead. Moreover, unique intellectual properties and global support provided by the company will likely drive its forthcoming results. Furthermore, Synopsys’ strategy to return wealth to shareholders highlights its growth potential and stable liquidity position. However, competition from peers, a challenging technology spending environment and uncertainty regarding the exact time of realizing acquisition synergies keep us on the side-lines." (9/22/2017)
• 2. Royal Bank Of Canada analysts commented, "Synopsys reported a solid quarter raising its full year guidance and generating 26.9% operating margins (highest margin profile since July 2009). In addition, the top line suggests 7%+ growth for the full year which should sustain double digit EPS growth' Synopsys reported upside to both the top and bottom line and generated operating margins of 26.9% which was the highest level since Jul-09 (over 7 years ago). While the full year numbers were only slightly modified (+$10M to both the low-end and highend) we think the margin profiles showcased the long-term potential for Synopsys. As the company continues to see revenues grow over the next several years, margins should expand in lock-step after digesting a set of acquisitions (Coverity then Cigital/Codiscope). With fundamentals continuing to improve we also highlight a solid cash balance sheet that can be utilized for continued share repurchases and strategic acquisitions as well. Net Net: the long-term potential for Synopsys continues to improve and we raise our price target to $77 (from $66)." (2/16/2017)

Some companies that are related to Synopsys include Red Hat (RHT), Citrix Systems (CTXS), Cadence Design Systems (CDNS), Splunk (SPLK), SS&C Technologies Holdings (SSNC), Tyler Technologies (TYL), The Ultimate Software Group (ULTI), National Instruments Corporation (NATI), Micro Focus International plc (MCRO), Nice Systems (NICE), Nuance Communications (NUAN), Blackbaud (BLKB), Solera Holdings (SLH), Atlassian Corporation PLC (TEAM), FireEye (FEYE), Playtech PLC (PTEC), Okta (OKTA) and CommVault Systems (CVLT).

Synopsys' management team includes the folowing people:

• Aart J. de Geus, Chairman of the Board, Co-Chief Executive Officer
• Chi-Foon Chan, President, Co-Chief Executive Officer, Director
• Trac Pham, Chief Financial Officer
• Joseph W. Logan, Executive Vice President - Worldwide Sales and Corporate Marketing
• John F. Runkel Jr., General Counsel and Corporate Secretary
• Steven C. Walske, Lead Independent Director
• Janice Durbin Chaffin, Independent Director
• Bruce R. Chizen, Independent Director
• Deborah A. Coleman, Independent Director
• Mercedes Johnson, Independent Director

Synopsys' stock is owned by many different of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (10.31%), BlackRock Inc. (8.20%), State Street Corp (4.61%), Dodge & Cox (4.14%), JPMorgan Chase & Co. (3.06%) and Ameriprise Financial Inc. (2.85%). Company insiders that own Synopsys stock include Alfred Castino, Brian M Beattie, Chi-Foon Chan, Deborah A Coleman, Geus Aart De, John F Runkel Jr, John Schwarz, Joseph W Logan, Steven Walske, Sudhindra Kankanwadi and Trac Pham. View Institutional Ownership Trends for Synopsys.

Synopsys' stock was sold by a variety of institutional investors in the last quarter, including Dodge & Cox, Artisan Partners Limited Partnership, TIAA CREF Investment Management LLC, BlackRock Inc., FMR LLC, Swiss National Bank, Prudential Financial Inc. and State Street Corp. Company insiders that have sold Synopsys stock in the last year include Alfred Castino, Chi-Foon Chan, Geus Aart De, John F Runkel Jr, John Schwarz, Joseph W Logan, Steven Walske and Trac Pham. View Insider Buying and Selling for Synopsys.

Synopsys' stock was purchased by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, AJO LP, Koch Industries Inc., Vanguard Group Inc., Renaissance Technologies LLC, Wells Fargo & Company MN, Pictet Asset Management Ltd. and Capital Fund Management S.A.. View Insider Buying and Selling for Synopsys.

Shares of Synopsys can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of Synopsys stock can currently be purchased for approximately $80.36.